Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naive Infected Patients
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 22 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.